Screener
Tarsus Pharmaceuticals, Inc. TARS EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Tarsus Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The source filing: Tarsus Pharmaceuticals, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 7:25 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001819790-26-000064
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Other income (expense), net | (281) | (145) | (368) | (226) |
| Total other income (expense), net | 4,073 | 1,844 | 5,580 | 3,004 |
| Provision for income taxes | (2,716) | — | (5,068) | — |
| Net loss | $(18,551) | $(20,340) | $(25,518) | $(45,460) |
| Unrealized gain (loss) on marketable securities and cash equivalents | (259) | (46) | (938) | (140) |
| Comprehensive loss | $(18,810) | $(20,386) | $(26,456) | $(45,600) |
| Net loss per share, basic and diluted | $(0.43) | $(0.48) | $(0.59) | $(1.11) |
| Weighted-average shares outstanding, basic and diluted | 43,393,643 | 42,360,452 | 43,176,514 | 40,869,364 |
Item 1. Financial Statements
FAQ
- What is Tarsus Pharmaceuticals, Inc.'s EPS (diluted)?
- Tarsus Pharmaceuticals, Inc. (TARS) reported EPS (diluted) of -$0.43 in Q2 2026.
- How has Tarsus Pharmaceuticals, Inc.'s EPS (diluted) changed year-over-year?
- Tarsus Pharmaceuticals, Inc.'s EPS (diluted) increased by 10.4% year-over-year, from -$0.48 to -$0.43.
- What is the long-term trend for Tarsus Pharmaceuticals, Inc.'s EPS (diluted)?
- Over 4 years (2021 to 2025), Tarsus Pharmaceuticals, Inc.'s EPS (diluted) has grown at a 22.3% compound annual growth rate (CAGR), from -$0.72 to -$1.61.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.
Ask your AI about Tarsus Pharmaceuticals, Inc.'s eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude